The COVID-19 pandemic’s influence on healthcare systems led to mixed outcomes for patients with cirrhosis, showing stable infection rates but a rise in multi-drug resistant organism (MDRO) infections.
Cirrhosis patients face mixed infection outcomes amid pandemic healthcare shifts
- Post author:
- Post published:February 7, 2024
- Post category:uncategorized